2017 annual financial data
Xeris Biopharma Holdings 2017 Operating margin
Xeris Biopharma Holdings 2017 operating margin with verified reported values.
Direct answer
Operating margin was -1,711.38%.
Operating income was -26,629,000 USD and net income was -26,554,000 USD.
Operating cash flow was -24,663,000 USD.
Get free Xeris Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,556,000 USD
- Operating income
- -26,629,000 USD
- Net income
- -26,554,000 USD
- Operating cash flow
- -24,663,000 USD